Articles tagged with Peptides
Researchers found that Wen Dan Tang significantly reduced insomnia-related anxiety in a sleep-deprived rat model. The traditional Chinese Medicine remedy also prevented decreased Ghrelin levels following sleep deprivation and increased Ghrelin receptor mRNA expression in the hypothalamus.
Researchers at CAMH have developed a nasal spray that delivers a peptide to treat depression, providing an alternative therapeutic approach. The peptide treatment interferes with dopamine receptors, leading to anti-depressant effects and showing potential in relieving symptoms.
Scientists create peptide mimetic that can be controlled by light, increasing antimicrobial effect and reducing side effects. The development opens new options for treating local bacterial infections and may lead to new agents against cancer.
A team of MIT chemists has designed a way to manufacture peptides in mere hours, which could have a major impact on peptide drug development. The new system can assemble an entire peptide in under an hour, allowing for rapid testing and design of new peptides.
A team of scientists has discovered a new therapeutic target for Alzheimer's disease by blocking the production of key neurotoxic peptides linked to the condition. The drug candidate, E64d, has been shown to be safe in humans and has improved memory deficits in mouse models.
Researchers create experimental substances based on a tiny protein found in cone snail venom that could lead to the development of safe and effective oral medications for chronic nerve pain. The new substances are about 100 times more potent than morphine or gabapentin, with fewer side effects and lower risk of abuse.
Researchers at Henry Ford Hospital found that the peptide AcSDKP provides neurological protection when administered after a stroke, reducing neurovascular damage and improving outcomes. The study also showed that combining AcSDKP with tPA extended the therapeutic window for up to four hours after stroke.
A new paper diagnostic for cancer has been developed by MIT engineers, which can detect the disease in minutes using a urine sample. The technology relies on nanoparticles that interact with tumor proteins, releasing biomarkers that are easily detectable in urine.
Researchers are exploring the properties of amyloid beta peptides, implicated in Alzheimer's disease. By understanding their behavior, they hope to identify structures that lead to toxic aggregates and develop treatments.
Researchers have developed 'smart' gold nanoshells that target cancer cells specifically, delivering anticancer drugs and converting near-infrared light into heat. This breakthrough could lead to more effective cancer treatments by overcoming the limitation of traditional chemotherapy techniques.
Scientists have developed a faster and more specific method to detect bacteria-tainted food, using nanomechanical cantilevers that can identify eight different types of Salmonella. The technique has the potential to prevent food poisoning and save thousands of lives annually.
Researchers at Rice University have developed a novel biosensor that can detect multiple strains of salmonella pathogens in food quickly and easily. The sensor uses microcantilevers decorated with peptides to identify the presence of specific bacteria, delivering results within minutes and outperforming existing standard tests.
Scientists at Rensselaer Polytechnic Institute discovered the structural effects of V44M and V44A genetic mutations linked to FAD. The mutations lead to increased production of toxic Amyloid Beta 42 peptide, driving memory failure in patients.
A new vascular homing peptide, CAR, selectively targets hypertensive pulmonary arteries to enhance the effects of existing vasodilators without systemic side effects. The peptide retains its activity when given sublingually, offering a potential breakthrough in PAH treatment.
Researchers have developed nanoscale patches that can be used to sensitize targeted cell receptors, making them more responsive to signals. This technology holds promise for promoting healing and facilitating tissue engineering research.
Researchers developed a diagnostic method that reveals factors behind conditions thought to have environmental triggers by decoding an individual's immune system. The process identifies disease-specific antibodies and their corresponding antigens, providing insight into conditions like Type-1 diabetes, autism, and Alzheimer's disease.
Northwestern University researchers have developed a new technique to profile enzyme activities in cell lysate, providing a fast, low-cost, and label-free method for studying post-transcriptional processes. By using peptide arrays and SAMDI mass spectrometry, the researchers were able to identify patterns of enzyme activities and shed ...
Researchers at Houston Methodist have developed a technology that can detect breast cancer biomarkers in blood samples, potentially leading to early diagnosis. The technology uses carboxypeptidase N enzyme to separate and detect peptides created by the enzyme in blood serum proteins.
Researchers at UAB designed an antibody fragment that cleared Aβ peptide oligomers from the cerebral cortex, reversing anxiety and learning memory deficits in mice. The treatment also improved apolipoprotein levels, suggesting a potential therapeutic approach for Alzheimer's disease.
Researchers at Cardiff University have created a peptide linked to a light-responsive dye that triggers cell death in cancerous cells. The new pathway activation technology, called transient photoactivation, enables scientists to precisely define the area where peptides should act, leading to more effective treatment strategies.
Researchers have developed a simple and reliable urine test to detect blood clots, which can cause life-threatening conditions. The test uses synthetic biomarkers that can sense vascular diseases remotely from the urine.
Scientists at UTHealth Medical School developed a brown fat detection method that worked in an animal model, providing a new tool to fight obesity. The peptide probe can be used for whole-body imaging and localization of brown fat tissue.
Preclinical data published in PNAS shows ATSP-7041 suppresses tumor growth in animal models of multiple human xenograft models, including breast cancer and bone cancer. The peptide efficiently penetrates cell membranes and restores p53 function by inhibiting MDM2 and MDMX.
Researchers develop bioengineered peptide to distinguish tumors from healthy tissue, demonstrating promising results in imaging medulloblastomas in lab mice. The new approach offers real-time imaging and potential for targeted drug delivery to cranial tumors.
Researchers have developed two new classes of compounds that target the gamma-secretase enzyme to treat Alzheimer's disease. These compounds produce shorter forms of amyloid peptide 38, which do not aggregate into neurotoxic plaques. Early-onset hereditary forms of Alzheimer's may be linked to mutations in the APP protein gene, leading...
Researchers found that Arg-Phe-amide-related peptide-1 modulates the hypothalamus-pituitary-gonadal axis by inhibiting kisspeptin-activated gonadotropin-releasing hormone neurons. The study also revealed a potential role for gonadotropin-inhibitory hormone in regulating reproductive development.
A study found that collaborative care with brain-type natriuretic peptide (BNP) screening reduced the combined rates of left ventricular systolic dysfunction, diastolic dysfunction, and heart failure. BNP levels above 50 pg/mL identified patients at higher risk for cardiovascular events.
Researchers have synthesized peptides that change shape upon irradiation with light, allowing control of protein-protein interactions and endocytosis. These molecules have immediate applicability for studying cancer cells and developmental biology, paving the way for optopharmacology and personalized medicine.
A new study found a link between fetal exposure to bisphenol A (BPA) and lower levels of insulin-like peptide 3, a key testicular hormone. This could be a co-factor in the development of cryptorchidism, a common birth defect in boys.
A study found that diet high in saturated fat increased LD αβ levels, while diet low in saturated fat decreased these fractions. The study suggests that lipidation states of apolipoproteins and amyloid peptides may play a role in AD pathological processes.
Researchers at Tel Aviv University developed a peptide called NAP that protects and restores microtubule function in brain cells. In animal models with microtubule damage, NAP maintained or revived protein transport, ameliorating neurodegeneration symptoms.
Researchers at Araclon Biotech have developed a blood test to measure beta amyloid peptides, which are associated with Alzheimer's disease. The test shows a high level of association between peptide levels and the disease, suggesting a potential biomarker for early diagnosis.
Researchers at OHSU have discovered a strategy to increase the number of viral peptides that T cells recognize, allowing them to more effectively respond to HIV. The method uses cytomegalovirus (CMV) to generate SIV-specific T cells that can target multiple viral peptides, providing a better targeting system for the immune system.
Researchers have discovered a cell-permeable peptide that reduces nuclear NF-ĸB activity in vascular smooth muscle cells and macrophages of aortic plaques. The peptide also inhibits lesion development in mice with a high-fat diet.
Scientists have engineered a protein from flesh-eating bacteria to act as a molecular 'superglue' that adheres tightly and resists harsh conditions. This technology has potential applications in diagnostic tests for early detection of cancer cells and other diseases, offering new possibilities for medical breakthroughs.
Researchers found that egg white protein peptide RVPSL reduces blood pressure in laboratory rats, comparable to a low dose of Captopril. The study suggests that egg white peptides could become useful as an adjunct to high-blood-pressure medication.
Researchers found that peptides derived from soybean meal inhibit cancer cell growth by up to 73%, making it a potential nutraceutical for reducing colon, liver and lung cancer cell growth. This breakthrough could lead to the development of new cancer treatments.
Researchers genetically engineered tomatoes to produce a peptide that mimics the action of good cholesterol, reducing inflammation and plaque build-up in mice. The study suggests that targeting the small intestine may be a new strategy to prevent diet-induced atherosclerosis.
A recent study by the European Association of Urology has shown promising results for a combined vaccine and steroid drug therapy in treating chemotherapy-naive castration-resistant prostate cancer (CRPC). The therapy, which involves multi-peptide vaccination therapy with low-dose dexamethasone, has been shown to significantly improve ...
Researchers identified a genetic mutation that alters the kinetics of an ion channel in red blood cells, leading to anemia. The defect causes the channel to stay open too long, causing an ion leak and affecting the cell's volume regulation.
Scientists at UCLA discovered a peptide called hypocretin that increases happiness and alertness in humans, while another peptide MCH plays a key role in sleep regulation. The study provides a potential new approach to treating psychiatric disorders like depression.
Harvard researchers show that insulin-like peptides play a crucial role in regulating learning and memory by fine-tuning neuronal activity. The study reveals a bidirectional regulation of learning, with some peptides inhibiting learning while others facilitate it.
Penn researchers create a protein 'passport' that allows nanoparticles to bypass the immune system, facilitating targeted drug delivery and implant device functionality. The innovative approach could improve treatment efficacy by reducing inflammation and prolonging nanoparticle retention.
Researchers synthesized a peptide called Tat-beclin 1, which induces autophagy, a recycling process crucial for cell health. Mice treated with the peptide were resistant to several infectious diseases, including West Nile virus and HIV infection.
Scientists found that people with type 2 diabetes face twice the risk of developing Alzheimer's disease due to peptide deposits. Researchers discovered the molecular interactions between amyloid beta and amylin peptides, which may lead to protein aggregation and disease progression.
Duke University engineers developed a novel delivery system that overcomes the limitations of peptide drugs, which are used to treat diseases like diabetes and cancer. The new system, called POD, uses a fusion protein that releases the drug slowly and steadily, reducing side effects.
Researchers found a small peptide that blocks antibody recognition of desmogleins, improving cell-cell adhesion and preventing skin blistering in pemphigus vulgaris. Additionally, spironolactone reduced vascular calcification in kidney disease mice, increasing their life span. A glioblastoma fusion gene promoted tumor growth and progre...
Researchers develop small peptide that blocks antibody recognition of desmogleins, improving cell-cell adhesion and preventing skin blistering in mice. The peptide could serve as a potential treatment option for pemphigus vulgaris, a life-threatening autoimmune skin disease.
Scientists have developed a pill that breaks down gluten peptides, making it possible for people with celiac disease to consume gluten-containing foods. The enzyme, called KumaMax, has been engineered to break down over 95% of the offending peptides in acidic conditions like those in the stomach.
Researchers discovered an organic compound, D737, that restored motor function and longevity to fruit flies with Alzheimer's disease. The compound prevented protein clumps, a hallmark of the disease, by inhibiting amyloid beta 42 aggregation.
Researchers have engineered natural gut peptides to carry small steroids, improving insulin secretion, blood glucose, and body weight in mice. The study's findings suggest a potential breakthrough in treating type 2 diabetes and metabolic syndrome, with minimal risk of estrogen-related side effects.
Researchers at Queen Mary University of London discovered genes in sea urchins and sea cucumbers that can change collagen elasticity, potentially leading to new ways to keep skin looking young and healthy. The study found peptides that cause rapid stiffening or softening of collagen, which could be used to combat aging-related wrinkles.
Researchers at Kansas State University have designed a membrane-bounded vesicle formed entirely of peptides that can safely deliver drugs to specific cells in the body. The peptide vesicles offer advantages over existing drug delivery systems, such as improved stability and durability.
Researchers found that eliminating an enzyme called jnk3 leads to a 90% reduction in amyloid beta peptides, a hallmark of Alzheimer's disease. This finding suggests jk3 could be a new target for Alzheimer's intervention.
Researchers at Ohio State University discovered that combining two peptide agents with a low-dose chemotherapy drug can delay tumor onset and progression in breast cancer models. The treatments caused few side effects.
A new study found that gastric bypass surgery changes the gut microbiota composition in rats, increasing beneficial bacteria and altering peptide release. This shift resembles prebiotic treatment effects, suggesting a potential link between postsurgical gut modulations and improved metabolic outcomes.
Scientists have engineered a peptide inhibitor to target specific skin proteases, offering potential relief for people with conditions such as eczema and dermatitis. By modifying the binding surface of sunflower trypsin inhibitor, researchers created novel inhibitors that may help restore the skin's original state.
Researchers have mapped the female fruit fly's post-coital behavioral switch using neural circuitry analysis. The study reveals that stimulation of specific neuronal clusters triggers a dramatic change in behavior, influencing both the female's and male's actions.
A hybrid vaccine has demonstrated a 43% reduction in risk of recurrence, with an estimated rate of 10.3% compared to 18% in control group, in patients with varying levels of HER2 expression.
Researchers have designed and tested molecules that can block or enhance aspects of the immune system's activity, offering a potential new treatment for inflammatory diseases. The breakthrough, published in Journal of Medicinal Chemistry, uses a novel optimization-based approach to design peptides with unprecedented potency and precision.